Τόμος 1 (1983) – Τεύχος 2 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 1 (1983) – Issue 2– Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Εργαστήριο Μεταβολισμού Φαρμάκων Πανεπιστημίου Γενεύης

2.         Brodie, B.B., Burns, JJ„ Mark, L.C., Lief, P.A., Bernstein, E., Papper, E.M.: The fate of pentobarbital in man and dog and a method for its estimation in bioligical material. J. Pharmacol. Exp. Ther, 109:26 (1953)

3.         Butler, T.C.: Quantitative studies of the déméthylation of N-methyl barbital. J. Pharmacol. Exp. Therap. 108:478 (1953)

4.         Cooper, J.R., Brodie, B.B.: The enzymatic metabolism of hexobarbital. J. Pharmacol. Exp. Ther. 114:404 (1955)

5.         Quin, E.P., Axelrod, J., Brodie, B.B.: Species, strain and sex differences in metabolism of hexobarbitone, amidopyrine and aniline. Blochem. Pharmacol. 1:1952 (1958)

6.         Glasson, B., Benakis, A.: Etude du phénobarbital C-14 dans l’organisme du rat. Helv. Physiol. Acta 19:323 (1961)

7.         Loeser, E.W.Jr: Studies on the metabolism of diphenylhydantoin (Dilantin). Neurology 11:424 (1961)

8.         Qiasson, B., Benakis, A., Ernst, C.: Métabolisme et excrétion comparée de quelques médicaments anticonvulsivants. Thérapie XVIII:1483 (1963)

9.         Firemark, H., Barlow, C.W., Roth, L.J.: The entry accumulation and binding of diphenylhydantoin-2-14C  in brain. Studies on adult, immature and hypercapnic cats. Int. J. / Neuropharmacol 2:25 (1963)

10.       Burns, J.J., Yu, T.F., Dayton, P.G., Gutman, A.B., Brodie, B.B.: Biochemical pharmacological considerations of phenylbutazone and its analogous. Ann. N. Y. Acad. Sci. 86:253(1960)

11.        Hucker, H.B., Zacchei, A.G., Cox, S.V., Brodie, D.A., Cantwell, N.H.R.: Studies on the absorption, distribution and excretion of indomethacin in various species. J. Pharm. Exp. Ther. 153:237 (1966)

12.       Glasson, B., Benakis, A., Strolin-Benedetti, M.: Distribution, excretion, metabolism and localization of a new anti-inflamatorydrug: Niflumic acid, labelled with 14C. S/o-chem. Pharmacol. 18:633 (1969)

13.       Dring, L.G., Smith, R.L., Williams, R.T.: The fate of amphetamine in man and other marnais. J. Pharm. Pharmacol. 18:402 (1966)

14.       Ellison, T., Gutzait, L„ VanLoon, E.J.: The comparative metabolism of d-amphetamine- 14C in the rat, dog and monkey. J. Pharm. Epx. Ther. 152:383 (1966)

15.       Consolo, S., Dolfini, E„ Garattîni, S., Valzellî, L.: Desipramine and amphetamine metabolism. J. Pharm. Pharmacol. 19:253 (1967)

16.       Beckett, A.H., Tucker, G.T., Moffalt, A.C.: Routine detection and identification in urine of stimulants and other drugs which may be used to modify performance in sport. J. Pharm. Pharmacol. 19:273 (1967)

17.       Benakis, A., Thomasset, M.: Metabolism of amphetamines and their interaction with other drugs. Abuse of central stimulants, Almqvist and Wiksell, p.409, Stockholm, 1969 18.        Glasson, B., Benakis, A., Thomasset, M.: Localisation, distribution, excrétion et métabolisme d’un nouveau médicament  anorexigène marqué au ,4C: le Chlorhydrate de Clobenzorex. Arzneim. -Forsch. 21:1985 (1971)

19.       Burns, J.J.: Value of metabolic studies in the evaluation of new drugs in man. In: Evaluation of New Drugs in Man (E. Zaimis ed), p.21, Pergamon Press, Oxford, 1965

20.      Roth, L.J. Ed.: Isotopes in Experimental Pharmacology. Univers, of Chicago Press, Chicago, 1965

21.       Glasson, B., Benakis, A.: L’étude métabolique des médicaments marqués: description d’un plan expérimental. J. Lab. Comp. 11:210 (1966)

22.       Report of Drug Research Board, Committee on Problems of Drug Safety, Nat. Acad. Sciences- Nat. Res. Cone.: Application of metabolic data to evaluation of drug. CHn. Pharmacol. Thor. 10(5)301 (1969)

23.       Benakis, A.: Radioactive labelled compounds in drug metabolic studies. In; Synthesis and application of isotopically labelled compounds (Duncam, Susen eds), p.45, Elsevier Publ., 1982

24.       Glasson, B., Benakis, A.: Le métabolisme des médicaments marqués au ,4C et au 3H: De l’expérimentation animale à l’utilisation chez l’homme. Rev. Eur. Etud. Clin. Biol 76:209 (1971)

25.       Fouts, J.R.: The metabolism of drug by subtractions of hepatic microsomes. Biochem. Biophys. Res. Commun. 6:373 (1961)

26.       Glasson, B., Benakis, A.; Les effets du CCI4 sur le métabolisme du phénobarbital chez le rat. Heiv. Physiol. Acta 20:227 (1962)

27.       Remmer, H.: Drugs as activators of drug enzymes. Proc. 1st. Inter. Pharmacol. Mtg. Stockholm, vol.6, p.235, MacMillan, New York, 1962

28.      Gillette, J.R.; Metabolism of drugs and other foreign compounds by enzymatic mechanisms. Progr. Drug Res. 6:13 (1963)

29.       Fouts, J.R.: Factors influencing the metabolism of drugs in liver microsomes. Ann. N.Y. Acad. Sci. 104315 (1963)

30.      Remmer, H., Merker, H.J.: Effect of drugs on the formation of smoth endoplasmic reticulum and drug-metabolizing enzymes. Ann. N.Y. Acad. Sc. 123:79 (1965)

31.       Gillette, J.R.: Biochemistry of drug oxidation and reduction by enzymes in hepatic endoplasmatic reticulum. Adv. Pharmacol. 4:219 (1966)

32.       EIDeFrawy, S.: Factors effecting changes in components of the hepatic microsomal enzyme system system responsible for drug metabolism. Fed. Proc. 26:412 (1967)

33.       Conney, A.H., Welch, R.M., Kuntzman, R., Burns, J.J.: Effects of pesticides on drug and steroid metabolism. Clin. Pharmacol Ther. 8:2 (1967)

34.       Mannering, G.J.: Significance of stimulation and inhibition of drug metabolism in pharmacological testing. In: Selected Pharmacological Testing Methods (Burger, H. ed), p. 51, Marcel Dekkar Inc., New York, 1968

35.       Sasame, H.A., Castro, J.A., Gillette, J.R,: Studies on the destruction of liver microsomal cytochrome P-450 by carbon tetrachloride administration. Biochem. Pharmacol 77:1759 (1968)

36.       Uehleke, H., Greim, H.: Stimulierung der Oxydation von Frendstoffen in Nierenmikrosomen durch Phénobarbital. Arch. Pharmacol. Exp. Pathol. 261:152 (1968)

37.       Gillette, J.R., Conney, A.H., Cosmides, G.J., Estabrook, R.W., Fouts, J.R., Mannering, G.J. eds. Microsomes and Drug Oxidation. Acad, Press, N.Y., 1969

38.      Benakis, A., Corthay, J., Medilanski, P.: Effect of feeding irradiated fish on the drug-metabolizing liver enzymes in rat. Toxicol Appt. Pharmacol. 42:533 (1977)

39.       Benakis, A., Simona, M.: Evaluation de l’intoxication hépatique chez le rat par la mesure de la vitesse de la déméthylation de raminopyrine-14C et du taux des transaminases plasmatiques. Experientia 35:7 (1979)

40.      Conney, A.H., Burns, JJ.: Factors influencing drug metabolism. Adv. Pharmacol 7:31 (1962)

41.       Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 79:317 (1967)

42.       Sladek, N.E., Mannering, G.J.: Induction of drug metabolism. Moi. Pharmacol. 5:174 (1969)

43.       Benakis, A., Corthay, J., Medilanski, P., Dormard, Y., Lèvy, J.C.: Effet d’un extrait de fora sur le système microsomal hépatique et sur un modèle d’intoxication expérimentale. Com-Rend. Soc. Biol. 777:322 (1977)

44.       Gillette, J.R.: Individually different responses to drug according to age, sex, functional or pathologic state. In: Ciba Found. Symp. on Drug Responses in Man (C.E.W. Wolssterholme, R. PortBr eds), p. 24, J. and A. Churchill Ltd, London, 1967

45.       Solomon, H.M., Schrogie, J.J.: Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamid in human subjects. Metabolism 76:1029 (1967)

46.       Benakis, A., Tsoukas, G., Glasson, B.: Localization of butylmalonic acidmano-1,2-diphenyihydrazine) -calcium-14C, a new antiinflammatory drug, in rats and mice with whole- body autoradiography. Specific localization in the carragenine-inflamed paw and in general experimental polyarthritic rats. Arzeim.-Forschung 23:1231 (1973)

47.       Benakis, A.: The piace of mass spectrometry in drug metabolic studies. In: Recent Developments in Mass Spectrometry in Biochemistry and Medicine, vol.lt. Plenum Press, 1979

48.      Roncucci, R., Simon, M. -J., Jacques, G., Stables.isotopes in drug metabolism and pharmacokinetics. Eur. J. Drug Metabot. Pharmacok. 7:9 (1976)

49.       Benakis, A., Borllat, E.: The use of ,BN in drug metabolism studies by emisson spectrometry. 6th Eur. Work. Drug Metabol., Leiden, 1978

50.       Sugnaux, F.R., Benakis, A.: Metabolism of sulpiride: determination of the chemical structure of its metabolites in rat, dog and man. Eur. J. Drug Metabol Pharmacok. 4:235 (1978)

51.       Peskar, B.A., Peskar, B.M.: Advances in apten immunoassays. Eur. J. Drug Metabot. Pharmacok. 2:163 (1977)

52.       Mould, e.P., Aherne, G.W., Marks:  Radioimmunoassay of drugs and its clinical applications. Eur. J. Drug Metabol Pharmacok. 2:171 (1977)

53.       Schobben, F., van der Kleijn, E.: Drug determination in body flruds by enzyme multiplied immunoassay technique. Eur. J. Drug Metabol Pharmacok, 2:185 (1977)

54.       Benakis, A.: Specific localization of drugs at the hypophysis level and side effects: The case of neuroleptics. Acta Pharmacol Toxicol. 41:110 (1977)

55.       Benakis, A., Sugnaux, F.R., Fonzo, D., Gatlone, R., diCarlo: Dose-dependent pharmacokinetics of sulpiride and related product in secretion in man after oral administration. Eur J. Drug Metabol. Pharmacok. 6:1 (1983)

56.       Kirch, W., Gorg,. K.G.: Clinical pharmacokinetics of atenolol: a review, Eur J. Drug Metabot. Pharmacok. 7:81 (1982)

Έντυπη Μορφή (70 € + έξοδα αποστολής)
Printed Type (70 € + shipping)pharmakonpress[at]pharmakonpress[.]gr